News

New LDL-lowering therapy safe, effective in phase 2b trial

10.10.20141866

Esperion Therapeutics announced favorable top-line results from a phase 2b study assessing the safety and efficacy of a treatment for patients with hypercholesterolemia.

Go Red for Women: Results

09.10.20142953

В Москве завершилась акция «Оденься в красное!», прошедшая под эгидой Российского кардиологического общества, социально-образовательной программы «Пульс жизни» и концерна Bayer.

Long-Term Clinical Outcome of Major Adverse Cardiac Events in Survivors of Infectious Endocarditis: A Nationwide Population-Based Study

09.10.20141572

Substantial infective endocarditis (IE)-related morbidity and mortality may occur even after successful treatment.

Outcomes After Emergency Percutaneous Coronary Intervention in Patients With Unprotected Left Main Stem Occlusion: The BCIS National Audit of Percutaneous Coronary Intervention 6-Year Experience

08.10.20141645

What are the in-hospital outcomes and 3-year mortality of patients presenting with unprotected left main stem occlusion (ULMSO) treated with primary percutaneous coronary intervention (PPCI)?

Heart Failure as a Risk Factor for Diabetes Mellitus

07.10.20141566

Diabetes mellitus (DM) is a well-recognized risk factor for heart failure (HF).

High-Sensitivity Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) and Risk of Incident Heart Failure in Patients with CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

06.10.20141635

High-sensitivity troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) strongly predict heart failure (HF) in the general population.

Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Outpatients With Stable Coronary Artery Disease

03.10.20141557

What is the incidence and impact on outcome of bleeding in patients with stable coronary artery disease (CAD) who are at least 1 year past any coronary events (any myocardial infarction [MI] or revascularization)?